Adam P Vogel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Adam P Vogel

Showing results (141-150 of 143) with videos related to

Pageof 15

Sort By:

You have reached the last page of results.This site can display upto 143 results.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2025

Developing digital health technologies for frontotemporal degenerationNaomi Nevler, Debra Niehoff, Amanda M Gleixner, et al.

Journal of Neurology|April 8, 2015

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levelsEppie M Yiu, Geneieve Tai, Roger E Peverill, et al.

Brain : a Journal of Neurology|November 17, 2023

Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40Angela T Morgan, Thomas S Scerri, Adam P Vogel, et al.

Pageof 15

Search research articles

Showing results (141-150 of 143) with videos related to

Sort By:

Pageof 15

You have reached the last page of results.This site can display upto 143 results.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2025

Developing digital health technologies for frontotemporal degenerationNaomi Nevler, Debra Niehoff, Amanda M Gleixner, et al.

Journal of Neurology|April 8, 2015

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levelsEppie M Yiu, Geneieve Tai, Roger E Peverill, et al.

Brain : a Journal of Neurology|November 17, 2023

Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40Angela T Morgan, Thomas S Scerri, Adam P Vogel, et al.

Pageof 15